Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kufner

Showing results (341-350 of 370) with videos related to

Pageof 37
Sort By:
Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.
International Orthopaedics|December 20, 2013
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healingSlobodan Vukicevic, Hermann Oppermann, Donatella Verbanac, et al.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary SyndromesChristian Valina, Franz-Josef Neumann, Maurizio Menichelli, et al.
JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
Cardiovascular Intervention and Therapeutics|February 7, 2025
Comparative safety and efficacy of new-generation single-layer polytetrafluorethylene- versus polyurethane-covered stents in patients with coronary artery perforation for the RECOVER (REsults after percutaneous interventions with COVERed stents) InvestigatorsFelix Voll, Göran Olivecronab, Miroslaw Ferenc, et al.
Scientific Reports|September 15, 2016
Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup AnalysisRaphaela Lohaus, Jonathan Michel, Katharina Mayer, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
European Heart Journal. Cardiovascular Imaging|February 3, 2023
Machine learning identifies pathophysiologically and prognostically informative phenotypes among patients with mitral regurgitation undergoing transcatheter edge-to-edge repairTeresa Trenkwalder, Mark Lachmann, Lukas Stolz, et al.
The Canadian Journal of Cardiology|February 4, 2026
Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vesselsAlp Aytekin, Felix Voll, Fiorenzo Simonetti, et al.
Pageof 37

Showing results (341-350 of 370) with videos related to

Sort By:
Pageof 37
Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.
International Orthopaedics|December 20, 2013
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healingSlobodan Vukicevic, Hermann Oppermann, Donatella Verbanac, et al.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary SyndromesChristian Valina, Franz-Josef Neumann, Maurizio Menichelli, et al.
JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
Cardiovascular Intervention and Therapeutics|February 7, 2025
Comparative safety and efficacy of new-generation single-layer polytetrafluorethylene- versus polyurethane-covered stents in patients with coronary artery perforation for the RECOVER (REsults after percutaneous interventions with COVERed stents) InvestigatorsFelix Voll, Göran Olivecronab, Miroslaw Ferenc, et al.
Scientific Reports|September 15, 2016
Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup AnalysisRaphaela Lohaus, Jonathan Michel, Katharina Mayer, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
European Heart Journal. Cardiovascular Imaging|February 3, 2023
Machine learning identifies pathophysiologically and prognostically informative phenotypes among patients with mitral regurgitation undergoing transcatheter edge-to-edge repairTeresa Trenkwalder, Mark Lachmann, Lukas Stolz, et al.
The Canadian Journal of Cardiology|February 4, 2026
Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vesselsAlp Aytekin, Felix Voll, Fiorenzo Simonetti, et al.
Pageof 37